A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay

Clinical and Experimental Immunology
A M YamamotoJ F Bach

Abstract

Antibodies specific for cytochrome CYP2D6, formally known as liver-kidney-microsome type-1 antibodies (LKM-1), are characteristically found in a subgroup of patients presenting autoimmune hepatitis. They are also found in some patients with chronic HCV infection. These autoantibodies are usually detected by indirect immunofluorescence, immunoblotting and ELISA tests. In an attempt to set up a more sensitive detection assay we developed a quantitative immunoprecipitation radioligand assay using a 35S-methionine-labelled CYP2D6 antigen obtained by in vitro transcription and translation synthesis. All 16 sera from AIH-2 patients strongly bound to this CYP2D6 antigen. Two of the nine sera (22%) from AIH-2 patients that presented only liver cytosol-1 antibodies also bound to CYP2D6. All 24 sera from HCV patients that were positive for LKM-1 antibodies by indirect immunofluorescence were also positive using this CYP2D6 radioligand assay. Lastly, all 15 sera from HCV patients negative for LKM-1 antibodies were negative by this test. The present results support the view that this quantitative radioligand assay is more sensitive than immunoblotting and ELISA CYP2D6 assays, and that it could be used in combination with indirect immunoflu...Continue Reading

Citations

Dec 4, 2002·Journal of Clinical Pathology·N KerkarD Vergani
Feb 28, 2004·Journal of Autoimmunity·Kathie BélandFernando Alvarez
Mar 23, 2000·Journal of Hepatology·P Obermayer-StraubM P Manns
Aug 29, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric BallotAna Maria Yamamoto
Oct 5, 2002·Clinics in Liver Disease·Francesco B BianchiLuigi Muratori
Jan 9, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Cumali EfePaolo Muratori
Aug 11, 1999·Journal of Autoimmunity·I R MackayM J Rowley
Oct 7, 2004·Journal of Hepatology·Diego VerganiUNKNOWN International Autoimmune Hepatitis Group
May 4, 2001·Journal of Autoimmunity·P Obermayer-Straub, M P Manns
Dec 23, 2008·The American Journal of Gastroenterology·Marcella LiEdwin Liu
Jan 10, 2002·European Journal of Gastroenterology & Hepatology·Georgios N DalekosMichael P Manns
Nov 3, 2004·Autoimmunity·Diego Vergani, Giorgina Mieli-Vergani
Oct 23, 2004·Autoimmunity·Susana VitozziFernando Alvarez
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yun MaDiego Vergani
Oct 13, 2006·Current Opinion in Gastroenterology·D Vergani, G Mieli-Vergani
Dec 26, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·Masahiro KimuraNobuyuki Amino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.